BriaCell Therapeutics Corp. Warrant (BCTXZ) Stock Analysis

What BriaCell Therapeutics Corp. Warrant does

BriaCell Therapeutics Corp., a biotechnology company based in West Vancouver, Canada, is intensely focused on immuno-oncology, dedicated to engineering novel immunotherapies for cancer treatment. Its flagship compound, Bria-IMT, is a whole-cell cancer vaccine presently in Phase I/IIa clinical development, where it's being evaluated in conjunction with the investigational immunotherapy retifanlimab. The company's pipeline also includes Bria-OTS, a personalized, ready-to-use immunotherapy intended for advanced breast cancer, and BriaDx, a diagnostic tool for determining patient HLA types. BriaCell maintains a non-exclusive clinical trial collaboration with Incyte Corporation to explore the effects of combining various novel clinical candidates. Furthermore, a cooperative research and development agreement with the National Cancer Institute supports preclinical efforts to advance and test Bria-OTS cellular immunotherapy as a cancer therapy.

Key metrics

ETFs linked to BCTXZ

Broad-market and Healthcare sector ETFs an investor holding BriaCell Therapeutics Corp. Warrant is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BCTXZ fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for BriaCell Therapeutics Corp. Warrant?

BriaCell Therapeutics Corp. Warrant trades under the ticker BCTXZ on NASDAQ.

Which exchange is BCTXZ listed on?

BCTXZ is listed on NASDAQ.

What sector does BriaCell Therapeutics Corp. Warrant operate in?

BriaCell Therapeutics Corp. Warrant is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BCTXZ in a portfolio?

PortView shows BCTXZ's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.